These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26450985)

  • 21. Identification of putative noncanonical driver mutations in patients with essential thrombocythemia.
    Arai A; Yoshimitsu M; Otsuka M; Ito Y; Miyazono T; Nakano N; Obama K; Nakashima H; Hanada S; Owatari S; Nakamura D; Tokunaga M; Kamada Y; Utsunomiya A; Haraguchi K; Hayashida M; Fujino S; Odawara J; Tabuchi T; Suzuki S; Hamada H; Kawamoto Y; Uchida Y; Hachiman M; Ishitsuka K
    Eur J Haematol; 2023 Jun; 110(6):639-647. PubMed ID: 36811253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK and MPL mutations in myeloid malignancies.
    Tefferi A
    Leuk Lymphoma; 2008 Mar; 49(3):388-97. PubMed ID: 18297515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anagrelide and Mutational Status in Essential Thrombocythemia.
    Iurlo A; Cattaneo D; Orofino N; Bucelli C; Fabris S; Cortelezzi A
    BioDrugs; 2016 Jun; 30(3):219-23. PubMed ID: 27041108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
    Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
    J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms.
    Pietra D; Casetti I; Da Vià MC; Elena C; Milanesi C; Rumi E
    Am J Hematol; 2012 Jul; 87(7):746-7. PubMed ID: 22565617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
    Ahmed RZ; Rashid M; Ahmed N; Nadeem M; Shamsi TS
    Asian Pac J Cancer Prev; 2016; 17(3):923-6. PubMed ID: 27039813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calreticulin exon 9 mutations in myeloproliferative neoplasms.
    Ha JS; Kim YK
    Ann Lab Med; 2015 Jan; 35(1):22-7. PubMed ID: 25553276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK2V617F, CALR, and MPL Mutations and Bone Marrow Histology in Patients with Essential Thrombocythaemia.
    Pich A; Riera L; Francia di Celle P; Beggiato E; Benevolo G; Godio L
    Acta Haematol; 2018; 140(4):234-239. PubMed ID: 30404086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics of clonal evolution in a rare essential thrombocythemia with coexisting Type 2 CALR and MPL S204P mutations.
    Wang J; Fu W; Bao W; Gong W; Xu S; Ling C; Jin Q; Zhang Q
    Platelets; 2023 Dec; 34(1):2176167. PubMed ID: 36786035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next generation sequencing redefines a triple negative essential thrombocythaemia as double-positive with rare mutations on JAK2 V617 and MPL W515 hotspots.
    Beucher A; Dib M; Orvain C; Bouvier A; Jouanneau-Courville R; Dobo I; Cottin L; Guardiola P; Rousselet MC; Blanchet O; Hunault M; Ugo V; Luque Paz D
    Br J Haematol; 2019 Sep; 186(5):785-788. PubMed ID: 31087331
    [No Abstract]   [Full Text] [Related]  

  • 31. MPL W515L mutation in pediatric essential thrombocythemia.
    Farruggia P; D'Angelo P; La Rosa M; Scibetta N; Santangelo G; Lo Bello A; Duner E; Randi ML; Putti MC; Santoro A
    Pediatr Blood Cancer; 2013 Aug; 60(8):E52-4. PubMed ID: 23441089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JAK2 V617F and MPL W515L/K mutations in Korean patients with essential thrombocythemia.
    Kim HJ; Jang JH; Yoo EH; Kim HJ; Ki CS; Kim JW; Kim SH
    Korean J Lab Med; 2010 Oct; 30(5):474-6. PubMed ID: 20890078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical Characteristic of "triple-negative" Essential Thrombocythaemia Patients and Mutation Analysis by Targeted Sequencing].
    Ju MK; Fu RF; Li HY; Liu XF; Xue F; Chen YF; Huang YT; Zhang LY; Yang RC; Zhang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1137-1145. PubMed ID: 30111420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombopoietin Measurement as a Key Component in the Evaluation of Pediatric Thrombocytosis.
    Nelson ND; Marcogliese A; Bergstrom K; Scheurer M; Mahoney D; Bertuch AA
    Pediatr Blood Cancer; 2016 Aug; 63(8):1484-7. PubMed ID: 27100794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR.
    Wang Z; Tian X; Ma J; Zhang Y; Ta W; Duan Y; Li F; Zhang H; Chen L; Yang S; Liu E; Lin Y; Yuan W; Ru K; Bai J
    Cancer Med; 2024 Apr; 13(7):e7123. PubMed ID: 38618943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.
    Sangkhae V; Etheridge SL; Kaushansky K; Hitchcock IS
    Blood; 2014 Dec; 124(26):3956-63. PubMed ID: 25339357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of MPL W515L/K mutations in Taiwanese patients with Philadelphia-negative chronic myeloproliferative neoplasms.
    Lieu CH; Shen YJ; Lai WC; Tsai WH; Hsu HC
    J Chin Med Assoc; 2010 Oct; 73(10):530-2. PubMed ID: 21051030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia.
    Lambert MP; Jiang J; Batra V; Wu C; Tong W
    Am J Hematol; 2012 May; 87(5):532-4. PubMed ID: 22389068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAK2, MPL, and CALR mutations in children with essential thrombocythemia.
    Sekiya Y; Okuno Y; Muramatsu H; Ismael O; Kawashima N; Narita A; Wang X; Xu Y; Hama A; Fujisaki H; Imamura T; Hasegawa D; Kosaka Y; Sunami S; Ohtsuka Y; Ohga S; Takahashi Y; Kojima S; Shimada A
    Int J Hematol; 2016 Aug; 104(2):266-7. PubMed ID: 27209416
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
    Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
    Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.